LevitasBio Stock

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

Sign up today and learn more about LevitasBio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About LevitasBio Stock

Levitas is redefining cellular analytics with its novel platform of magnetic levitation technology. Their disruptive technology overcomes the current technological limitations of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.

Funding History

August 2017$8.0M
January 2021$18.0M
October 2022$35.0M

Management

CEO

Martin Pieprzyk

Scientific Co-Founder

Lars Steinmetz

Co-Founder

Gozde Durmus

Co-Founder

Utkan Demirci

General Manager Europe

Harry Boeltz

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo